All Employment articles – Page 5
-
Business
Pfizer to close Cambridge pain outpost
120 jobs under threat from closure of Neusentis subsidiary R&D site
-
Business
Job cuts at Daiichi, Perrigo and Cabot
Staff reductions aimed at cutting costs or, in Perrigo’s case, fending off a takeover bid
-
Business
Biogen to cut 800 jobs worldwide
US biotech is reducing its workforce by 11% and cancelling several R&D programmes to cut costs
-
Business
Monsanto plans 2600 layoffs
Sales losses prompt agrochemical giant to slash workforce by 12% over the next two years
-
Business
Merger fever sweeps pharma
The life sciences sector has been gripped by a mergers and acquisition frenzy, and it looks set to continue. But what does it mean for the industry?
-
Business
Job cuts at Allergan and Transgene
Allergan is shedding 300 staff at former Actavis site in Iceland, while Transgene is closing its French manufacturing plant with loss of 120 jobs
-
Business
BMS sues executive for joining rival company
Bristol-Myers Squibb’s lawsuit against its former immuno-oncology chief who left to work for AstraZeneca has implications for biopharma industry
-
Business
Takeda to consolidate vaccines business in Boston
Firm will close three recently-acquired US sites and shift operations to the growing pharmaceutical hub in Massachusetts
-
Business
Zoetis to sell or close 10 plants in cost-cutting drive
Animal health firm will slash product portfolio in a bid to save $300m annually
-
Business
Dow to shed up to 1750 jobs by 2017
Chemical giant will lay off about 3% of its global workforce in the next two years
-
Business
Amgen to axe 300 Onyx employees
Amgen will close its Onyx facility in South San Francisco in December
-
Business
Mergers and moves trigger pharma layoffs
Shire expects to sack 500 or more employees, while Merck and GSK also wield the axe
-
Business
AstraZeneca to spin off anti-infectives research
Early-stage research will transfer to a new company, while AZ and MedImmune retain late-stage programmes
-
Business
Huntsman looks to cut jobs and titania capacity
900 employees face axe as firm evaluates titanium dioxide options
-
Business
GSK cuts US jobs in push for savings
Research Triangle Park site bears the brunt as drugmaker consolidates research in Philadelphia and Stevenage, UK